PLAAT3 and neoplasm: PLA2G16 null mice are resistant to high fat diet or leptin deficiency induced obesity through the PGE2-EP3-cAMP pathway [8], suggesting PLA2G16 may contribute to tumor progression through altered metabolic pathways.